Shahrouz Khoshbakht
Overview
Explore the profile of Shahrouz Khoshbakht including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
88
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gravand A, Alesaeidi S, Khoshbakht S, Saghaei M, Kenarangi T, Mosallaei M, et al.
Clin Rheumatol
. 2023 Aug;
42(12):3387-3395.
PMID: 37597101
Introduction/objectives: Considering the phenotypic and serological heterogeneity of systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), significant challenges may intervene with the precise diagnosis. In this regard, numerous studies have...
2.
Ehtesham N, Mosallaei M, Beheshtian M, Khoshbakht S, Fadaee M, Vazehan R, et al.
Arch Iran Med
. 2023 Aug;
25(12):788-797.
PMID: 37543906
Background: Ion channel dysfunction in the brain can lead to impairment of neuronal membranes and generate several neurological diseases, especially neurodevelopmental disorders. Methods: In this study, we set out to...
3.
Mosallaei M, Ehtesham N, Beheshtian M, Khoshbakht S, Davarnia B, Kahrizi K, et al.
Mol Genet Genomic Med
. 2022 Feb;
10(4):e1894.
PMID: 35174982
Background: Guanine nucleotide exchange factors (GEFs) play pivotal roles in neuronal cell functions by exchanging GDP to GTP nucleotide and activation of GTPases. We aimed to determine the genotype and...
4.
Sohrabi B, Dayeri B, Zahedi E, Khoshbakht S, Pour N, Ranjbar H, et al.
Cancer Gene Ther
. 2022 Jan;
29(8-9):1105-1116.
PMID: 35082400
Mesenchymal stem cells (MSCs) are known as promising sources for cancer therapy and can be utilized as vehicles in cancer gene therapy. MSC-derived exosomes are central mediators in the therapeutic...
5.
Khoshbakht S, Beheshtian M, Fattahi Z, Bazazzadegan N, Parsimehr E, Fadaee M, et al.
Arch Iran Med
. 2021 Jul;
24(5):364-373.
PMID: 34196201
Background: Neurodevelopmental and intellectual impairments are extremely heterogeneous disorders caused by a diverse variety of genes involved in different molecular pathways and networks. Genetic alterations in cilia, highly-conserved organelles with...
6.
Ataei R, Khoshbakht S, Beheshtian M, Abedini S, Behravan H, Dizghandi S, et al.
Arch Iran Med
. 2019 Nov;
22(8):461-471.
PMID: 31679349
Many genes with different inheritance modes contribute to the pathogenicity of intellectual disability (ID) making it the most known genetically heterogeneous disorder. Advanced next-generation sequencing (NGS) technologies have helped researchers...
7.
Mehrjoo Z, Fattahi Z, Beheshtian M, Mohseni M, Poustchi H, Ardalani F, et al.
PLoS Genet
. 2019 Sep;
15(9):e1008385.
PMID: 31550250
Iran, despite its size, geographic location and past cultural influence, has largely been a blind spot for human population genetic studies. With only sparse genetic information on the Iranian population...
8.
Larki P, Khoshbakht S, Rezaei N
Acta Med Iran
. 2014 Mar;
52(1):91-2.
PMID: 24658996
No abstract available.
9.
Taghavi N, Biramijamal F, Abbaszadegan M, Khademi H, Sotoudeh M, Khoshbakht S
Arch Iran Med
. 2010 May;
13(3):235-42.
PMID: 20433229
Background: The incidence of esophageal squamous cell carcinoma (ESCC) is very high in northeastern Iran. However, the genetic predisposing factors to ESCC in this region have not been clearly defined....